Antitumor activity of drug loaded glycyrrhetinic acid modified alginate nanoparticles on mice bearing orthotopic liver tumor

J Control Release. 2011 Nov 30:152 Suppl 1:e111-3. doi: 10.1016/j.jconrel.2011.08.158.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alginates / chemistry*
  • Animals
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / chemistry
  • Antibiotics, Antineoplastic / metabolism
  • Antibiotics, Antineoplastic / pharmacology*
  • Chemistry, Pharmaceutical
  • Doxorubicin / administration & dosage
  • Doxorubicin / chemistry
  • Doxorubicin / metabolism
  • Doxorubicin / pharmacology*
  • Drug Carriers*
  • Drug Compounding
  • Glucuronic Acid / chemistry
  • Glycyrrhetinic Acid / chemistry*
  • Hexuronic Acids / chemistry
  • Humans
  • Injections, Intravenous
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / pathology
  • Mice
  • Nanoparticles*
  • Technology, Pharmaceutical / methods
  • Tissue Distribution
  • Tumor Burden / drug effects
  • Xenograft Model Antitumor Assays

Substances

  • Alginates
  • Antibiotics, Antineoplastic
  • Drug Carriers
  • Hexuronic Acids
  • Doxorubicin
  • Glucuronic Acid
  • Glycyrrhetinic Acid